血栓成分与急性缺血性卒中溶栓及取栓疗效
本文为范围综述,遵循Joanna Briggs研究所方法,检索MEDLINE、EMBASE、SCOPUS和Web of Science,纳入95篇主题相关文献,总结血栓成分对机械取栓和溶栓疗效的影响。结果显示卒中血栓成分高度异质,富含纤维蛋白的血栓与取栓次数增多、手术时间延长及临床结局较差相关。
要点
- 卒中血栓成分高度异质,含纤维蛋白、血小板、红细胞、VWF和中性粒细胞胞外诱捕网。
- 血栓可大致分为富含纤维蛋白和富含红细胞两类。
- 富含纤维蛋白血栓与取栓次数增多、手术时间延长及临床结局较差相关。
核心结论
- 血栓成分可能影响机械取栓和溶栓疗效,富含纤维蛋白血栓与取栓次数增多、手术时间延长及临床结局较差相关。
研究设计与样本
- 范围综述,遵循Joanna Briggs研究所方法,检索MEDLINE、EMBASE、SCOPUS和Web of Science,纳入95篇主题相关文献。
主要发现
- 卒中血栓成分高度异质,含纤维蛋白、血小板、红细胞、VWF和中性粒细胞胞外诱捕网。
- 血栓可大致分为富含纤维蛋白和富含红细胞两类。
- 与富含红细胞血栓相比,富含纤维蛋白血栓与取栓次数增多、手术时间延长及临床结局较差相关。
临床怎么用
- 考虑血栓异质性可能有助于改进未来的血管内治疗和溶栓治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombi retrieved from patients with acute ischemic stroke are highly heterogeneous. Recent data suggest that thrombus composition may impact on mechanical thrombectomy, the number of recanalization manoeuvres, resistance to retrieval, and on thrombolytic potential. Our aim was to summarize evidence describing the impact of thrombus composition on efficacy of mechanical thrombectomy and thrombolysis in patients with acute ischemic stroke. The scoping review methodology guided by the Joanna Briggs Institute, an adaption of the Arksey and O'Malley, was followed. Comprehensive searches were conducted in MEDLINE, EMBASE, SCOPUS, and Web of Science. Articles were classified into 4 key themes: (1) composition of stroke thrombi, (2) thrombus composition and mechanical thrombectomy, (3) thrombus composition and thrombolytic therapy, and (4) novel imaging and endovascular approaches. Our search identified 698 articles published from 1987 to June 2020. Additional articles were extracted from reference lists of the selected articles. Overall, 95 topic-specific articles identified for inclusion published in 40 different journals were included. Reports showed that thrombus composition in stroke was highly heterogeneous, containing fibrin, platelets, red blood cells, VWF (von Willebrand Factor), and neutrophil extracellular traps. Thrombi could roughly be divided into fibrin- and red blood cell-rich clots. Fibrin-rich clots were associated with increased recanalization manoeuvres, longer procedure time, and less favorable clinical outcomes compared with red blood cell-rich clots. Advances in detection or treatment of thrombi that take into account clot heterogeneity may be able to improve future endovascular and thrombolytic treatment of stroke.
引用
- Jolugbo P, Ariëns RAS. Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke. Stroke. 2021. PMID: 33563020. doi:10.1161/STROKEAHA.120.032810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。